Galimedix Therapeutics
Galimedix Therapeutics

Galimedix Therapeutics

Measured by AhrefsDR26Ahrefs DR: 26/100. Below median. Measured by Ahrefs. Median 44.Measured by StartupHub.aiAgent26Agent Readiness: 26/100. Bottom 25%. Measured by StartupHub.ai. Median 41.Measured by Google PageSpeedSpeed75Site Speed: 75/100. Above median. Measured by Google PageSpeed. Median 62.Measured by StartupHub.aiTrust85Data Trust: 85/100. Top 25%. Measured by StartupHub.ai. Median 61.

Galimedix Therapeutics is a clinical-stage biopharmaceutical company developing novel radiopharmaceuticals for PET imaging.

2018Active12Copenhagen, Denmark

About

Galimedix Therapeutics is a clinical-stage biopharmaceutical company developing next-generation small molecule therapies for neurodegenerative diseases. Their lead candidate, GAL-101, is in Phase 2 clinical testing for dry age-related macular degeneration (AMD), glaucoma, and Alzheimer's disease, aiming to block a key step in the neurodegenerative process with a well-tolerated compound. These therapies are designed for convenient administration as eye drops or oral tablets, serving patients and caregivers with a focus on improved tolerability.

Key facts

Website
galimedix.com
Headquarters
Copenhagen, Denmark
Founded
2018
Employees
12
Business model
B2B

Tech stack

Detected on galimedix.com, last scanned 3 Nov 2026.

Frontend
jQuery
Analytics
Google Analytics 4
SEO
Yoast SEO
CMS / Builders
WordPress
Email provider
Microsoft 365

Test your Ahrefs DR

The backlink strength of a domain, on the Ahrefs 0 to 100 scale. About a minute.

Write the first review

Frequently asked

Is Galimedix Therapeutics trustworthy and reputable?

StartupHub's Data Trust & Reputation score for Galimedix Therapeutics is 85 out of 100, a trusted rating, based on site security posture, privacy practices, malware and phishing checks, and public reputation signals.

How many employees does Galimedix Therapeutics have?

Galimedix Therapeutics has approximately 12 people on record.

SEC filings, insider activity, nonprofit links and pay benchmarks for Galimedix Therapeutics:

Company details: from public sources. Funding: no announced round on file. Ownership: not yet claimed by the company. Scores: measured by named tools; each links to its method. Our rules